Biological
Twinrix clinical trials
- studies test it
- 12
- open now
- 0
- in phase 3
- 2
- first study started
- 2003
How studies write it
Studies that test it under each name
Name
- Twinrix
- 10
Combined with it in one product
Studies by the year they started
12 studies that test it; most in 2004 (4)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 4 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 2
- Phase 3
- 2
- Phase 4
- 7
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 7
GlaxoSmithKline (5) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · University of North Carolina, Chapel Hill (1) · Dartmouth-Hitchcock Medical Center (1) · St. Joseph's Health Care London (1) · University of Aarhus (1) · IDEWE Occupational Health Services (1) · Mount Sinai Hospital, Canada (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses twinrix is read from its arms, and is right about nine times in ten.
Testing it · 12
- Determining Responses to Two Different Vaccines in HIV and HCV Infected IndividualsCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00393276Written as Twinrix
- Combination Hepatitis A and B Vaccine to Induce Immunity in Non-respondersWithdrawnPhase 4Mount Sinai Hospital, CanadaNCT01126853Written as Twinrix
- Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B VaccCompletedPhase 4GlaxoSmithKlineNCT00289731Written as TWINRIX™
- Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy AdultsCompletedPhase 3GlaxoSmithKlineNCT00289770Written as Twinrix™
- Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary VaccinationCompletedPhase 4GlaxoSmithKlineNCT00684671Written as Twinrix
- Primary Study to Demonstrate Non-inferiority and Immunogenicity of GSK Biologicals' Meningococcal Vaccine 134612CompletedPhase 3GlaxoSmithKlineNCT00465816Written as Twinrix
- Effectiveness of Two Hepatitis B Vaccines in HIV-negative YouthsCompletedPhase 2University of North Carolina, Chapel HillNCT00107042Written as Twinrix
- Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in AdultsCompletedPhase 4GlaxoSmithKlineNCT00603252Written as Twinrix
- Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse DisorderCompletedPhase 2Dartmouth-Hitchcock Medical CenterNCT00316303Written as Twinrix
- Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-respondersStatus unknownPhase 4University of AarhusNCT01451801Written as Twinrix
- Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis PatientsCompletedPhase 4St. Joseph's Health Care LondonNCT00186836Written as Engerix-B and Twinrix
- Twinrix Alternative Schedule StudyStatus unknownPhase 4IDEWE Occupational Health ServicesNCT00216229Written as Combined vaccine against hepatitis A and B (Twinrix)